
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Scripta Therapeutics Raises $12M to Find Disease-Modifying Drugs Altering Transcription Factors
Details : The financing will support the development of an undisclosed product for Alzheimer's disease.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
November 13, 2025
